SS Innovations International (NASDAQ: SSII) announced it has been awarded the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an honor recognizing excellence in innovation, commercial success, industry leadership and positive societal impact. The company stated that the award reflects the increasing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction due to its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures have been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also noted that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries.
The SSi Mantra system is designed to make robotic surgery more accessible and affordable globally. SS Innovations, an American company headquartered in India, plans to expand its global presence with its technologically advanced and cost-effective surgical robotic solutions. The company's product range includes the SSi Mantra system and its comprehensive suite of SSi Mudra surgical instruments, supporting a variety of procedures including cardiac surgery.
For more details, the full press release is available at https://ibn.fm/XWdRe. SS Innovations encourages interested parties to visit the Company’s website at ssinnovations.com for more information and updates. Please see full terms of use and disclaimers on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
Forward-looking statements in this article involve risks, uncertainties, and other factors that may cause actual results to differ materially. These forward-looking statements are subject to various factors beyond management's control, including those set forth under "Risk Factors" in the Company's most recent Annual Report on Form 10-K and other SEC filings. Undue reliance should not be placed on these forward-looking statements, and the Company undertakes no duty to update this information unless required by law.
